Recruiting

ASTHMAXcel Voice Study

The objective of this study is to conduct a randomized controlled trial (RCT) to compare the adapted and refined ASTHMAXcel Voice platform to usual care (UC). It is hypothesized by the investigator team that ASTHMAXcel Voice will be associated with improved clinical and process outcomes, asthma quality of life (QOL), medication adherence, and self-efficacy as compared to UC.

ClinicalTrials.gov IDNCT06935084

PhaseNA

Enrollment200

SponsorMontefiore Medical Center

Age18 Years

SexALL

I'm interested View official listing

Conditions studied

Asthma

About this study

Interventions

Other: ASTHMAXcel Voice platform — ASTHMAXcel Voice is a mobile health application with a multi-level approach to address barriers with intervention components and facilitate health behavior change through the use of push notifications and interactive educational content.

Primary outcomes

Change in Asthma Control (Change from Baseline to 6 months after randomization)

Eligibility information

Inclusion Criteria: * English speaking * Persistent asthma (diagnosed by a healthcare provider) on a daily controller medication * Able to provide informed consent * Smartphone access (iOS or Android) with data plan Exclusion Criteria: * Pregnancy * Severe psychiatric or cognitive problems that would prohibit completion of protocol

Study locations

Montefiore Medical Center, The Bronx, New York 10467 United States

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.